Milestone · Healthcare & Life Sciences

Innovaccer completes Rs 600 crore ESOP buyback

By Startup Enthusiast · 13 January 2026

What they do

Innovaccer is a healthcare data and analytics platform for hospitals, health systems, and insurers

The company completed a Rs 600 crore (~$75 million) ESOP buyback, providing liquidity to current and former employees with vested stock options

The buyback follows a $275 million Series F round last year and comes amid muted ESOP activity in 2025

Innovaccer completed an ESOP buyback (employee stock option plan buyback, where the company repurchases shares from employees' vested stock options) worth Rs 600 crore (~$75 million).
The buyback provided liquidity to current and former employees with vested stock options.
CEO Abhinav Shashank said the buyback aimed to convert employee ownership into tangible outcomes.
The buyback involved repurchasing shares from exercised stock options, with no new shares issued or dilution.
The buyback follows the company's $275 million Series F round last year.
Series F participants included B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.
The buyback comes amid muted ESOP activity in 2025, with total ESOP buybacks, payouts, and liquidity at just over $75 million for the year.

The buyback is part of Innovaccer's strategy to reward employees and convert their ownership into tangible financial outcomes.
It follows a $275 million Series F round, indicating strong investor confidence and available capital.
The buyback occurs against a backdrop of declining ESOP liquidity in the Indian startup ecosystem, with 2025 activity at just over $75 million compared to $190 million in 2024.
The company's strong financial performance, with Rs 387.71 crore operating revenue and Rs 36.1 crore profit in FY ended March 2025, supports such liquidity events.

Innovaccer is a healthcare data and analytics platform for hospitals, health systems, and insurers.
Its products include the Healthcare Intelligence Cloud and Data Activation Platform, which unify EHR (electronic health records), claims, and other data.
Key customers include CommonSpirit Health, Kaiser Permanente, and Banner Health.
The company has a strong footprint in the US healthcare market, working with provider networks and payers.
Innovaccer generates revenue by selling its platform to healthcare organizations, with operating revenue of Rs 387.71 crore in FY ended March 2025.
The company has made several acquisitions, including Cured (patient experience/CRM) and Pharmacy Quality Solutions (pharmacy performance) in 2024.
In September 2025, it acquired Story Health (AI-enabled specialty care) and Humbi AI (actuarial and contracting copilots).
New product launches include Innovaccer Gravity (healthcare intelligence platform for AI operationalisation), Flow (AI-driven prior authorisation), and Comet (AI-powered access centre).

Product: healthcare data and analytics platform that helps hospitals, health systems and insurers unify clinical, financial and operational data
Customers: Hospitals, health systems, and health insurers that buy software to unify data and automate care workflows
How it makes money: Subscription software and platform services for healthcare organizations
What sets it apart: Best-in-KLAS recognition across multiple categories and a broad healthcare data platform